Literature DB >> 12147667

Fatal disseminated toxoplasmosis in a toxoplasma seropositive liver transplant recipient.

D Wendum, N Carbonell, M Svrcek, O Chazouilléres, J-F Fléjou.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12147667      PMCID： PMC1769724          DOI： 10.1136/jcp.55.8.637

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  8 in total

Review 1.  Disseminated toxoplasmosis after liver transplantation: case report and review.

Authors:  M Lappalainen; T S Jokiranta; L Halme; O Tynninen; I Lautenschlager; K Hedman; K Höckerstedt; S Meri
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

2.  Diagnosis of toxoplasmosis in bone marrow transplant recipients: comparison of PCR-based results and immunohistochemistry.

Authors:  T K Held; D Krüger; A R Switala; J Beyer; D Kingreen; C Busemann; K Janitschke; W Siegert
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

3.  Disseminated toxoplasmosis in a liver transplant patient.

Authors:  C W Anthony
Journal:  J Am Med Womens Assoc (1972)       Date:  1972-11

4.  Disseminated toxoplasmosis in the compromised host. A report of five cases.

Authors:  T H Gleason; W B Hamlin
Journal:  Arch Intern Med       Date:  1974-12

5.  Septic shock due to toxoplasmosis in patients infected with the human immunodeficiency virus.

Authors:  J C Lucet; M P Bailly; J P Bedos; M Wolff; B Gachot; F Vachon
Journal:  Chest       Date:  1993-10       Impact factor: 9.410

6.  Role of bronchoalveolar lavage in diagnosis of disseminated toxoplasmosis.

Authors:  F Jacobs; M Depierreux; M Goldman; M Hall; C Liesnard; F Janssen; C Toussaint; J P Thys
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

7.  Transmission of Toxoplasma gondii infection by liver transplantation.

Authors:  J T Mayes; B J O'Connor; R Avery; W Castellani; W Carey
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

8.  Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis.

Authors:  A Roth; B Roth; K N Arasteh; K Janitschke
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948
  8 in total
  6 in total

1.  Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection.

Authors:  Jun-Jun He; Jun Ma; Hany M Elsheikha; Hui-Qun Song; Si-Yang Huang; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2016-08-03       Impact factor: 3.876

2.  Hepatic Metabolomics Investigation in Acute and Chronic Murine Toxoplasmosis.

Authors:  Xiao-Qing Chen; Hany M Elsheikha; Rui-Si Hu; Gui-Xue Hu; Shu-Ling Guo; Chun-Xue Zhou; Xing-Quan Zhu
Journal:  Front Cell Infect Microbiol       Date:  2018-06-05       Impact factor: 5.293

3.  Histopathological, Immunohistochemical and Biochemical Studies of Murine Hepatosplenic Tissues Affected by Chronic Toxoplasmosis.

Authors:  Samah Hassan Yahia; Samia Elsayed Etewa; Nesreen Saeed Saleh; Samira Metwally Mohammad; Nora Ibrahim Aboulfotouh; Ahmad Mansour Kandil; Mohamed Hassan Sarhan
Journal:  J Parasitol Res       Date:  2022-06-16

4.  Seroepidemiology of Toxoplasma gondii infection in patients with liver disease in eastern China.

Authors:  A L Tian; G X Li; H M Elsheikha; D S Gardner; X Y Zhang; W Dong; X P Yang; Y Y Luo; H L Li; W Cong; X Q Zhu
Journal:  Epidemiol Infect       Date:  2017-07-05       Impact factor: 4.434

5.  Beyond the disease: Is Toxoplasma gondii infection causing population declines in the eastern quoll (Dasyurus viverrinus)?

Authors:  Bronwyn A Fancourt; Stewart C Nicol; Clare E Hawkins; Menna E Jones; Chris N Johnson
Journal:  Int J Parasitol Parasites Wildl       Date:  2014-05-29       Impact factor: 2.674

6.  Proteomic Profiling of Mouse Liver following Acute Toxoplasma gondii Infection.

Authors:  Jun-Jun He; Jun Ma; Hany M Elsheikha; Hui-Qun Song; Dong-Hui Zhou; Xing-Quan Zhu
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.